The proposal would eliminate health-plan-run PBMs in Medicaid and establish a single state-contracted PBM, a move supporters ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

President Trump's nominee for health secretary, Robert F. Kennedy Jr., was questioned harshly by both Democrats and ...

The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Iowa lawmakers introduce bills to stop Pharmacy Benefit Managers from giving pharmacies less money than it costs to fill prescriptions.

According to the survey cited by NCPA, 60.4% of independent pharmacists are considering not stocking one or more of the first ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

GRAND JUNCTION, Colo. (KJCT) -A bipartisan bill was introduced into the house this week regarding healthcare costs for Coloradans. The bill introduced by Representatives Kyle Brown and Dusty Johnson ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.